CCM
MDGL icon

Cinctive Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Cinctive Capital Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.02M Buy
15,326
+11,639
+316% +$5.56M 0.53% 56
2025
Q4 		$2.15M Buy
3,687
+81
+2% +$41.4K 0.12% 201
2025
Q3 		$1.65M Sell
3,606
-1,162
-24% -$434K 0.08% 270
2025
Q2 		$1.44M Buy
4,768
+3,677
+337% +$1.1M 0.08% 253
2025
Q1 		$361K Sell
1,091
-4,315
-80% -$1.42M 0.03% 276
2024
Q4 		$1.67M Buy
5,406
+332
+7% +$93.4K 0.09% 237
2024
Q3 		$1.08M Buy
+5,074
New +$1.3M 0.06% 286
2024
Q1 		– Sell
-2,350
Closed -$544K – 470
2023
Q4 		$544K Buy
+2,350
New +$411K 0.04% 305

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return